Form D · Other

CytomX Therapeutics Holdings, LLC

Santa Barbara, CA · CIK 0001465584

Offering snapshot reported Feb 13, 2015 · SEC filing

Reported sold
$1.5M
Offering amount: $1.5M
Investors reported
40
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Feb 11, 2015
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Feb 13, 2015Initial$1,500,612No comparison40SEC filing
Apr 29, 2014Initial$1,423,488No comparison25SEC filing
Sep 10, 2012Initial$1,238,807No comparison25SEC filing
Sep 23, 2010Initial$2,660,000No comparison32SEC filing
Mar 3, 2010Amendment$2,500,000$875,000vs Dec 17, 200919SEC filing
Dec 17, 2009Amendment$1,625,000$125,000vs Oct 21, 20092SEC filing
Oct 21, 2009Amendment$1,500,000$500,000vs Jun 4, 20099SEC filing
Jun 4, 2009Initial$1,000,000No comparisonNot reportedSEC filing

Offering details

Securities
Equity, Other
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-234034
Proceeds used for working capital.
Series C Preferred Units

Source: Form D, filed Feb 13, 2015. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Alan Heeger Director, Executive
Michael Pfau Executive
Nancy Stagliano Executive
Gary Wilcox Director, Executive

Issuer details

Industry: Other (See others in industry)

Address:
1421 State St., Ste. B
Santa Barbara, CA, 93101